Social challenges


Grants for Collaborative Projects, including Research, innovation close to market, Coordination and Support Actions, and other new schemes (i.e. prizes, innovative public procurement, etc…) oriented to Political Priorities and Challenges of the Europe 2020 Strategy.

Need funding for your R&D project?


  GRANTS FOR EFFECTIVE HEALTH PROMOTION, DISEASE PREVENTION, PREPAREDNESS AND SCREENING
PHC 4 – 2015 Health promotion and disease prevention: improved inter-sector co-operation for environment and health based interventions CALL CLOSED
Specific challenge: Better health promotion and disease prevention interventions can make a significant contribution to equitable health improvements and thus the sustainability of health and care systems. A "health in all policies" approach has...
PHC 5 – 2014 Health promotion and disease prevention: translating ‘omics’ into stratified approaches CALL CLOSED
Specific challenge: "Omics" research (including but not limited to genomics, epi-genomics, meta-genomics and proteomics) is moving at a breath-taking pace. A major challenge for the next decade is to determine when and how this wealth of ‘omics’...
PHC 6 – 2014 Evaluating existing screening and prevention programmes CALL CLOSED
Specific challenge: Some existing population based screening and disease prevention programmes have not been assessed for their effectiveness, or vary in terms of their application within and across countries throughout Europe. This may result in...
PHC 7 – 2014 Improving the control of infectious epidemics and foodborne outbreaks through rapid identification of pathogens CALL CLOSED
Specific challenge: Human and animal health worldwide is increasingly threatened by potential epidemics caused by existing, new and emerging infectious diseases (including from antimicrobial resistant pathogens), placing a burden on health and veterinary...
PHC 8 – 2014 Vaccine development for poverty-related and neglected infectious diseases: Tuberculosis CALL CLOSED
Specific challenge: Vaccines offer a safe and cost-effective way to protect large populations against infectious diseases, or at least to mitigate the clinical course of these diseases. Yet many poverty-related and neglected infectious diseases continue...
PHC 9 – 2015 Vaccine development for poverty-related and neglected infectious diseases: HIV/AIDS CALL CLOSED
Specific challenge:Vaccines offer a safe and cost-effective way to protect large populations against infectious diseases, or at least to mitigate the clinical course of these diseases. Furthermore, they may in combination with other treatment modalities...